USADA and Anti-Doping

The pre-2015 era

Before July 2015, MMA's PED testing was the responsibility of individual state athletic commissions. The Nevada State Athletic Commission ran the most aggressive program (random testing, year-round), but most other commissions tested only the day-of-event or not at all. The lack of consistent testing produced an era where TRT (Testosterone Replacement Therapy) exemptions were routine, multiple champions tested positive after retirement, and the broader fan understanding was that PED use at championship level was widespread.

Famous pre-2015 incidents:

• Anderson Silva vs Nick Diaz (UFC 183, January 2015): both tested positive — Silva for steroids drostanolone and androstanediol, Diaz for marijuana. Result overturned to a No Contest.
• Vitor Belfort's TRT exemption (2011-2014): the explicit medical exemption for testosterone replacement that ended in late 2014 when the Nevada commission banned TRT in MMA.
• Wanderlei Silva's evasion (2014): refused to take a random test, leading to a 9-month suspension that was eventually overturned.

The USADA era (July 2015 - December 2023)

In July 2015, the UFC announced a partnership with the United States Anti-Doping Agency (USADA) to implement a comprehensive year-round anti-doping program for all UFC-contracted athletes. The program included:

• Year-round random testing: out-of-competition urine and blood samples collected at unannounced visits.
• WADA-compliant prohibited list: substances banned aligned with the World Anti-Doping Agency's annual list.
• Sanctioning for failures: positive tests resulted in suspensions ranging from 6 months (for low-impact substances) to 4 years (for major steroid use).
• Whereabouts requirements: top contracted athletes had to provide quarterly whereabouts information so USADA could conduct surprise testing.

The program's first year produced multiple high-profile suspensions. Notable USADA-era cases:

• Brock Lesnar's UFC 200 return (July 2016): tested positive for clomiphene (an estrogen modulator). Result overturned to NC, $250,000 fine, 1-year suspension.
• Jon Jones at UFC 214 (July 2017): tested positive for turinabol metabolites. Result overturned to NC. Eventually attributed to contamination via a third-party tested-positive arbitration.
• TJ Dillashaw vs Henry Cejudo (January 2019): Dillashaw tested positive for EPO post-fight. Suspended 2 years, vacated bantamweight title.
• Yoel Romero (multiple incidents): two contamination findings related to a tainted supplement. The Romero cases became a canonical example of "contamination vs intentional use" disputes.
• Conor McGregor's absence period (2021-2024): McGregor was in the USADA testing pool but was repeatedly delayed in returning to USADA's mandatory 6-month test window after his UFC 264 leg break.

The transition to CSAD (2024)

In late 2023, the UFC announced it would end the USADA partnership and instead partner with Combat Sports Anti-Doping (CSAD) under Drug Free Sport International. The transition took effect on January 1, 2024.

The change was controversial. USADA had built the most respected anti-doping program in any major US sport; the transition to a smaller, less-experienced provider was widely interpreted as the UFC seeking a more pliable partner. The transition also came around the time of high-profile cases — particularly the McGregor return-from-injury timeline — where the USADA whereabouts and testing requirements were politically inconvenient.

Key CSAD-era differences:

• Reduced out-of-competition testing volume: CSAD's collection rate is lower than USADA's was at peak.
• WADA list still in force: the prohibited substances list has not changed.
• Sanctioning regimen broadly similar: 2-4 year suspensions for major findings.
• Less independence: USADA was a fully independent agency; CSAD operates with closer commercial relationships to its testing clients.

TUEs (Therapeutic Use Exemptions)

A TUE allows a fighter to use an otherwise banned substance for a documented medical condition. Common TUEs in MMA:

• Asthma medications: inhaled corticosteroids for fighters with documented asthma.
• ADHD stimulants: prescription Adderall or similar.
• Hormone replacement: limited TUEs for documented hypogonadism (much more restrictive post-2014 TRT ban).

TUE applications require documentation from a licensed physician and approval from both the anti-doping agency and the applicable state athletic commission. Approval rates are tightly tracked and a fighter's TUE history becomes part of their compliance file.

Notable suspensions of the modern era

• Jon Jones (multiple): cocaine test (2015, not WADA-prohibited at the time), turinabol (UFC 214, 2017), atypical T:E ratio finding (2018 — eventually cleared).
• TJ Dillashaw: 2-year suspension for EPO (2019); returned and challenged for the bantamweight title at UFC 280.
• Anderson Silva: 1-year suspension after the UFC 183 dual positive.
• Wanderlei Silva: 3-year suspension for test refusal (later reduced).
• Hector Lombard: 1-year suspension for desoxymethyltestosterone.
• Sean O'Malley (2018): suspended 6 months for ostarine.
• Cris Cyborg (2011): 1-year Strikeforce-era suspension for stanozolol; she has tested clean across all USADA and CSAD-era programs since.

The structural critique

The MMA anti-doping system has structural weaknesses that the USADA and CSAD eras have not fully resolved:

• State commission coordination: federal-level USADA tests can be supplemented or contradicted by state commission tests. A fighter testing clean with USADA can still face a state commission disciplinary process and vice versa.
• Contamination findings: most USADA-era positives have been attributed by fighters to tainted supplements. The arbitration system has been generous to fighters who can demonstrate clean intent, which has produced inconsistent outcomes between fighters with similar test results.
• Detection lag: many PEDs are detectable for only days to weeks after use. Year-round testing reduces but does not eliminate the "cycle off before the test" strategy.
• Sanctioning consistency: similar offenses have produced widely varying suspension lengths depending on context, fighter status, and the specific commission involved.

The 2024 CSAD transition is too recent to fully evaluate. The next 2-3 years of suspensions and disciplinary process will determine whether the new program operates at the technical level USADA established or represents a meaningful regression.